Expanding Access to Home-Based Palliative Care
This study will test the effectiveness of integrating an evidence-based model of home-based palliative (HBPC) within primary care clinics on patient and caregiver outcomes. The investigators will conduct a randomized controlled trial, randomizing 1,155 seriously ill patients (and approximately 884 family caregivers) who receive primary care from 30-40 regional accountable care organizations (ACOs) in California to one of two study groups: HBPC or enhanced usual care (EUC). Follow-up data will be collected via telephone surveys with patients at 1- and 2-months and with caregivers at 1- and 2-months, and, as appropriate, following the death of the patient.
Checked against the public recordLast updated Sep 22, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Southern California
- Interventions being studied
- Other: Home-based palliative care; Other: Enhanced usual care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. 18 years of age or older; 2. diagnosis of HF, COPD, or advanced cancer; 3. one or more hospitalizations or ED visits in the previous year; 4. an Australia-Modified Karnofsky Performance Scale score of 70% or less; and 5. English- or Spanish-speaking. Exclusion Criteria: 1. is receiving hospice care; 2. has end-stage renal disease; and/or 3. lives in a nursing home.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- USC Davis School of GerontologyLos Angeles, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 22, 2025. Always confirm current availability with the study team.